Latest Drugs, Latest Approval in Miscellaneous antineoplastics

What are Miscellaneous antineoplastics?

Antineoplastics or anticancer drugs affect growth and cell division i.e. are antiproliferative. They work by different mechanisms to prevent the development and spread of neoplastic cells.

They also affect rapidly dividing normal cells, therefore are likely to suppress the bone marrow, suppress growth, impair healing, cause sterility and cause hair loss.

Name Updated
Xpovio 80 mg twice-weekly (Selinexor [ sel-i-nex-or ]) 19-Oct-2023
Xpovio 60 mg twice-weekly (Selinexor [ sel-i-nex-or ]) 19-Oct-2023
Xpovio 40 mg twice-weekly (Selinexor [ sel-i-nex-or ]) 19-Oct-2023
Xpovio 40 mg once-weekly (Selinexor [ sel-i-nex-or ]) 19-Oct-2023
Talquetamab (Talquetamab) 17-Oct-2023
Krazati (Adagrasib) 06-Oct-2023
Kymriah (Tisagenlecleucel [ tis-a-jen-lek-loo-sel ]) 05-Sep-2023
Erwinaze (Asparaginase erwinia chrysanthemi) 31-Aug-2023
Naxitamab (Naxitamab [ nax-it-a-mab ]) 17-Aug-2023
Enfortumab vedotin (Enfortumab vedotin [ en-fort-ue-mab-ve-doe-tin ]) 16-Aug-2023
Ciltacabtagene autoleucel (Ciltacabtagene autoleucel [ sil-ta-kab-ta-jeen-aw-toe-loo-sel ]) 16-Aug-2023
Bexarotene (Bexarotene [ bex-ar-oh-teen ]) 16-Aug-2023
Amivantamab (Amivantamab [ am-ee-van-ti-mab ]) 16-Aug-2023
Tisotumab vedotin (Tisotumab vedotin [ tye-sot-ue-mab-ve-doe-tin ]) 16-Aug-2023
Tisagenlecleucel (Tisagenlecleucel [ tis-a-jen-lek-loo-sel ]) 16-Aug-2023
Mitotane (Mitotane [ mye-toe-tane ]) 16-Aug-2023
Calaspargase pegol (Calaspargase pegol [ kal-as-par-jase-peg-ol ]) 15-Aug-2023
Brexucabtagene autoleucel (Brexucabtagene autoleucel [ brex-ue-kab-ta-jeen-ah-toe-loo-sel ]) 15-Aug-2023
Verteporfin (Verteporfin [ ver-te-pore-fin ]) 15-Aug-2023
Venclexta (Venetoclax [ ven-et-oh-klax ]) 15-Aug-2023
Sotorasib (Sotorasib [ soe-tor-a-sib ]) 15-Aug-2023
Moxetumomab pasudotox (Moxetumomab pasudotox [ mox-e-toom-oh-mab-pa-soo-doe-tox ]) 14-Aug-2023
Mosunetuzumab (Mosunetuzumab [ moe-sun-e-tooz-ue-mab ]) 14-Aug-2023
Lisocabtagene maraleucel (Lisocabtagene maraleucel [ lis-oh-kab-ta-jeen-mar-a-loosel ]) 14-Aug-2023
Lenalidomide (Lenalidomide [ len-a-lid-oh-mide ]) 14-Aug-2023
Isotretinoin (eqv-absorica) (Isotretinoin (oral) [ eye-so-tret-i-noyn ]) 14-Aug-2023
Inotuzumab ozogamicin (Inotuzumab ozogamicin [ in-oh-tooz-ue-mab-oh-zoe-ga-mye-sin ]) 14-Aug-2023
Elzonris (Tagraxofusp [ tag-rax-oh-fusp ]) 14-Aug-2023
Elotuzumab (Elotuzumab [ el-oh-tooz-ue-mab ]) 14-Aug-2023
Venetoclax (Venetoclax [ ven-et-oh-klax ]) 14-Aug-2023
Tice bcg live (for intravesical use) (Bcg intravesical (bee cee jee)) 14-Aug-2023
Sacituzumab govitecan (Sacituzumab govitecan [ sak-i-tooz-ue-mab-goe-vi-tee-kan ]) 14-Aug-2023
Pegaspargase (Pegaspargase [ peg-ah-spar-jase ]) 14-Aug-2023
Mogamulizumab (Mogamulizumab [ moe-gam-ue-liz-ue-mab ]) 13-Aug-2023
Mirvetuximab soravtansine (Mirvetuximab soravtansine [ mir-ve-tux-i-mab-soe-rav-tan-seen ]) 13-Aug-2023
Loncastuximab tesirine (Loncastuximab tesirine [ lon-kas-tux-i-mab-tes-ir-een ]) 13-Aug-2023
Ivosidenib (Ivosidenib [ eye-voe-sid-e-nib ]) 13-Aug-2023
Idecabtagene vicleucel (Idecabtagene vicleucel [ eye-de-kab-ta-jeen-vik-loo-sel ]) 13-Aug-2023
Dinutuximab (Dinutuximab [ din-ue-tux-i-mab ]) 13-Aug-2023
Belzutifan (Belzutifan [ bel-zoo-ti-fan ]) 13-Aug-2023
Belantamab mafodotin (Belantamab mafodotin [ bel-an-ta-mab-ma-foe-doe-tin ]) 13-Aug-2023
Asparaginase erwinia chrysanthemi (Asparaginase erwinia chrysanthemi [ as-par-a-jin-ase-er-win-ee-a-kri-san-the-mee ]) 13-Aug-2023
Arsenic trioxide (Arsenic trioxide [ ar-sen-ik-trye-ox-ide ]) 13-Aug-2023
Aldesleukin (Aldesleukin [ al-des-loo-kin ]) 13-Aug-2023
Topotecan (oral/injection) (Topotecan (oral/injection) [ toe-poe-tee-kan ]) 12-Aug-2023
Teclistamab (Teclistamab) 12-Aug-2023
Tebentafusp (Tebentafusp [ te-ben-ta-fusp ]) 12-Aug-2023
Tazemetostat (Tazemetostat [ taz-e-met-oh-stat ]) 12-Aug-2023
Talimogene laherparepvec (Talimogene laherparepvec [ tal-im-oh-jeen-la-her-pa-rep-vek ]) 12-Aug-2023
Tagraxofusp (Tagraxofusp [ tag-rax-oh-fusp ]) 12-Aug-2023